Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Claude LeBlanc | Chief Executive Officer, Director | $9.39M | +$271K | +2.97% | Feb 28, 2025 |
David Trick | Exec VP, CFO & Treasurer | $2.53M | +$39.8K | +1.6% | Feb 28, 2025 |
Jeffrey Scott Stein | Director | $2.1M | +$271K | +14.8% | Jan 1, 2025 |
Stephen Michael Ksenak | Sr. MD & General Counsel | $1.96M | +$55K | +2.89% | Feb 28, 2025 |
R. Sharon Smith | Exec VP & Chief Strategy Offr | $1.64M | +$11.7K | +0.72% | Feb 28, 2025 |
David Barranco | Senior Managing Director | $1.34M | Feb 28, 2025 | ||
Ian David Haft | Director | $1.32M | Jan 1, 2025 | ||
Michael D. Price | Director | $1.29M | +$1M | +339% | Jan 1, 2025 |
C. James Prieur | Director | $1.25M | Jan 3, 2023 | ||
David L. Herzog | Director | $1.24M | Apr 3, 2023 | ||
Joan M. Lammtennant | Director | $1.05M | Jan 1, 2025 | ||
Alexander David Greene | Director | $989K | May 12, 2021 | ||
Robert Bryan Eisman | Sr. MD & CAO | $975K | Feb 28, 2025 | ||
Lisa G. Iglesias | Director | $612K | Jan 1, 2025 | ||
Kristi Ann Matus | Director | $394K | +$101K | +34.4% | Jan 1, 2025 |
Daniel McGinnis | Sr. MD & COO | $292K | Feb 28, 2025 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|